Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,174,152
+$173,481 QoQ
Shares Held
4,666
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#2,400
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RIVERSEDGE ADVISORS, LLC holds $8,081,117 across 10 Drug Manufacturers - General names. ABBV ranks #3 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,231 | $1,582,487 | |
| 2 | LLY |
ELI LILLY & Co
|
1,159 | $1,390,139 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,666 | $1,174,152 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
19,575 | $1,127,911 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,880 | $884,080 | |
| 6 | NVS |
Novartis AG
|
3,883 | $608,543 | |
| 7 | AZN |
Astrazeneca PLC
|
2,280 | $432,333 | |
| 8 | BIIB |
Biogen Inc.
|
1,746 | $377,240 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,174,152 | 4,666 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,000,671 | 4,601 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,080,529 | 4,729 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,048,644 | 4,529 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $700,344 | 3,773 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $770,405 | 3,677 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $646,650 | 3,639 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $702,041 | 3,555 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $595,174 | 3,470 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $633,525 | 3,479 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $522,713 | 3,373 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $551,372 | 3,699 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $406,615 | 3,018 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $480,341 | 3,014 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $425,195 | 2,631 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $335,525 | 2,500 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $382,900 | 2,500 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $405,275 | 2,500 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $346,353 | 2,558 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $269,675 | 2,500 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $281,600 | 2,500 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $270,550 | 2,500 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $267,875 | 2,500 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $218,975 | 2,500 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $245,450 | 2,500 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||